首頁 > 市場調查報告書 > 醫療設備

體外診斷

非侵入性產前檢測 (NIPT) 市場規模、佔有率和成長分析（按產品、檢測方法、技術、懷孕風險、懷孕週數、應用和地區分類）：產業預測（2026-2033 年）

市場調查報告書

商品編碼

1898007

非侵入性產前檢測 (NIPT) 市場規模、佔有率和成長分析（按產品、檢測方法、技術、懷孕風險、懷孕週數、應用和地區分類）：產業預測（2026-2033 年）

Non-Invasive Prenatal Testing (NIPT) Market Size, Share, and Growth Analysis, By Product (Consumables, Reagents), By Testing Method, By Technology, By Pregnancy Risk, By Gestation Period, By Application, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球非侵入性產前檢測 (NIPT) 市場規模預計在 2024 年達到 41.6 億美元，從 2025 年的 45.6 億美元成長到 2033 年的 94.9 億美元，在預測期（2026-2033 年）內複合年成長率為 9.6%。

由於非侵入性產前檢測 (NIPT) 能夠透過對母體血液中胎兒遊離DNA進行基因分析，檢測出常見的染色體異常，例如21三體症候群和18三體症候群，因此全球NIPT市場正經歷顯著成長。 NIPT的優點包括能夠確定胎兒血型和Rh因子，以及由於孕婦群體老化而無創技術趨勢。 MaterniT21 PLUS和Harmony等主要廠商正在拓展其產品和服務。儘管不斷擴大的醫保報銷範圍和技術進步推動了市場擴張，但訓練有素的專業人員短缺和嚴格的監管等挑戰仍然是市場發展的障礙。亞太地區的新興市場為NIPT的進一步成長和創新提供了機會。

全球無創產前檢測 (NIPT) 市場促進因素

全球非侵入性產前檢測 (NIPT) 市場的發展主要得益於先進篩檢技術的不斷進步，這些技術能夠早期、準確地檢測胎兒的基因異常。各公司正優先研發創新無創產前診斷工具，並積極建立策略聯盟和合作關係，以擴大市場佔有率。人類基因定序技術的進步為染色體異常檢測領域帶來了顯著進展。此外，許多國家已採納非侵入性產前篩檢通訊協定來識別染色體異常，這反映出各國越來越重視透過先進的產前檢測技術來改善母嬰健康。

全球無創產前檢測（NIPT）市場面臨的限制因素

全球非侵入性產前檢測（NIPT）市場面臨許多挑戰，主要原因是檢測費用高昂，導致許多開發中國家難以獲得這項服務。例如，在印度，NIPT 的典型價格分佈為 350 至 400 美元，這成為其廣泛普及的一大障礙。此外，新興國家大眾對遺傳疾病風險的認知不足也阻礙了市場成長。這些因素，再加上人均醫療保健支出有限以及檢測報銷政策不完善，共同阻礙因素著全球 NIPT 市場的發展。

全球無創產前檢測（NIPT）市場趨勢

全球非侵入性產前檢測 (NIPT) 市場正經歷顯著的趨勢轉變，非侵入性檢測的普及得益於技術進步以及人們對其臨床療效和經濟優勢的日益認可。隨著醫療法規對非侵入性通訊協定的支持力度不斷增加，這些檢測方法正逐漸成為多個地區產前篩檢的標準方法。在荷蘭等國家，這種轉變尤其明顯，非侵入性診斷已成為孕婦的首選。儘管對於某些疾病，侵入性檢測仍然至關重要，但非侵入性檢測在全球範圍內的普及速度仍在持續加快，這反映出整個行業正朝著以患者為中心、更安全的產前護理解決方案轉型。

貝瑞基因股份有限公司（中國）
華大基因股份有限公司（中國）
Eurofins LifeCodexx GmbH（德國）
F. Hoffmann-La Roche Ltd.（瑞士）
GE醫療（美國）
Natera公司（美國）
美國實驗室控股公司（LabCorp）（美國）
Illumina公司（美國）
Myriad Genetics, Inc.（美國）
Quest Diagnostics Incorporated（美國）
賽默飛世爾科技公司（美國）
Sonic Healthcare Limited（澳洲）
Centogene NV（德國）
珀金埃爾默公司（美國）
Cordlife集團股份有限公司（新加坡）

結論與建議

簡介目錄

Product Code: SQMIG35J2080

Global Non-Invasive Prenatal Testing (NIPT) Market size was valued at USD 4.16 Billion in 2024 and is poised to grow from USD 4.56 Billion in 2025 to USD 9.49 Billion by 2033, growing at a CAGR of 9.6% during the forecast period (2026-2033).

The global market for non-invasive prenatal testing (NIPT) is experiencing significant growth as it leverages genetic analysis of fetal cell-free DNA in maternal blood to detect common chromosomal abnormalities like trisomy 21, trisomy 18, and others. Its advantages include the ability to ascertain the fetus's blood type and Rh factor, alongside a trend toward non-invasive methods over invasive procedures due to rising maternal age. Key players in this space, like MaterniT21 PLUS and Harmony, are diversifying offerings. Market expansion is supported by increasing insurance reimbursements and advancements in technology, while challenges such as a shortage of trained professionals and stringent regulations pose obstacles. Emerging markets in the Asia-Pacific region present opportunities for further growth and innovation in NIPT.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Invasive Prenatal Testing (NIPT) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Invasive Prenatal Testing (NIPT) Market Segments Analysis

Global Non-Invasive Prenatal Testing (NIPT) Market is segmented by Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User and region. Based on Product, the market is segmented into Consumables, Reagents and Instruments. Based on Testing Method, the market is segmented into Ultrasound Detection, Biochemical Screening Tests and Cell-Free DNA in Maternal Plasma Tests. Based on Technology, the market is segmented into NGS, Array Technology, PCR and Others. Based on Pregnancy Risk, the market is segmented into High Risk, Average Risk and Low Risk. Based on Gestation Period, the market is segmented into 0-12 Weeks, 13-24 Weeks and 25-36 Weeks. Based on Application, the market is segmented into Trisomy, Microdeletion Syndrome and Others. Based on End User, the market is segmented into Hospitals, Clinics, Diagnostic Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Non-Invasive Prenatal Testing (NIPT) Market

The Global Non-Invasive Prenatal Testing (NIPT) market is driven by the continuous advancement of highly sophisticated screening techniques that ensure early and accurate detection of genetic abnormalities in fetuses. Companies are prioritizing the development of innovative noninvasive prenatal diagnostic tools and are engaging in strategic partnerships and collaborations to enhance their market presence. Notable progress in detecting aneuploidies has been bolstered by advancements in human genome sequencing. Additionally, various countries are adopting non-invasive prenatal screening protocols aimed at identifying chromosomal abnormalities, reflecting a growing emphasis on improving maternal and fetal health outcomes through advanced technology in prenatal testing.

Restraints in the Global Non-Invasive Prenatal Testing (NIPT) Market

The Global Non-Invasive Prenatal Testing (NIPT) market faces significant challenges primarily due to the high costs associated with these tests, which render them inaccessible in many developing countries. For instance, in India, the typical price range for NIPT can be between USD 350 and USD 400, creating barriers to widespread adoption. Additionally, a general lack of awareness regarding genetic disorder risks among populations in emerging nations further hinders growth. Compounding these issues are factors such as limited per capita healthcare expenditure and inadequate reimbursement policies for testing, all of which contribute to the constraints faced by the NIPT market on a global scale.

Market Trends of the Global Non-Invasive Prenatal Testing (NIPT) Market

The Global Non-Invasive Prenatal Testing (NIPT) market is witnessing a significant trend towards non-invasive examinations driven by advancements in technology and the heightened awareness of their clinical efficacy and economic advantages. As healthcare regulations increasingly favor non-invasive protocols, these testing methods are becoming standard practice for prenatal screenings in various regions. The shift is particularly notable in countries like the Netherlands, where non-invasive diagnostics have become the primary option for pregnant women. Despite the remaining relevance of invasive tests for specific conditions, the global uptake of non-invasive testing continues to accelerate, reflecting a broader industry transformation towards patient-friendly and safer prenatal care solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Product & CAGR (2026-2033)

Market Overview
Consumables
Reagents
Instruments

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Testing Method & CAGR (2026-2033)

Market Overview
Ultrasound Detection
Biochemical Screening Tests
Cell-Free DNA in Maternal Plasma Tests

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Technology & CAGR (2026-2033)

Market Overview
NGS
Array Technology
PCR
Others

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Pregnancy Risk & CAGR (2026-2033)

Market Overview
High Risk
Average Risk
Low Risk

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Gestation Period & CAGR (2026-2033)

Market Overview
0-12 Weeks
13-24 Weeks
25-36 Weeks

Global Non-Invasive Prenatal Testing (NIPT) Market Size by Application & CAGR (2026-2033)

Market Overview
Trisomy
Microdeletion Syndrome
Others

Global Non-Invasive Prenatal Testing (NIPT) Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Clinics
Diagnostic Laboratories
Others

Global Non-Invasive Prenatal Testing (NIPT) Market Size & CAGR (2026-2033)

North America (Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User)
- US
- Canada
Europe (Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Testing Method, Technology, Pregnancy Risk, Gestation Period, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Berry Genomics Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Genomics Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins LifeCodexx GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Natera, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratory Corporation of America Holdings (LabCorp) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Myriad Genetics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sonic Healthcare Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Centogene N.V. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordlife Group Limited (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments